Objective
To evaluate the efficacy of magnetic stimulation (MStim) added to bladder training (BT) on incontinence‐related quality of life (QoL) and clinical parameters in women with idiopathic overactive bladder (OAB).
Material and Methods
Seventy‐six women with idiopathic OAB were randomized into two groups using the random numbers generator as follows: Group 1 received BT alone (n: 38), and Group 2 received BT + MStim (n: 38). MStim was performed with MStim therapy armchair (Novamag NT60), 2 days a week, 20 min a day, a total of 12 sessions for 6 weeks. Women were evaluated in terms of incontinence severity (24‐h pad test), 3‐day voiding diary (frequency of voiding, incontinence episodes, nocturia, and number of pads), symptom severity (OAB‐V8), QoL (IIQ‐7), positive response and cure–improvement rates, and treatment satisfaction (Likert scale) at the baseline and the end of treatment (sixth week).
Results
A statistically significant improvement was found in incontinence severity, frequency of voiding, incontinence episodes, nocturia, number of pads, symptom severity, and QoL parameters for two groups at the end of the treatment compared to the baseline values (p < 0.05). At the end of treatment; incontinence severity, incontinence episodes, nocturia, number of pads, symptom severity, and QoL were significantly improved in Group 2 compared to Group 1 (p < 0.05). No difference was found between the two groups in terms of frequency of voiding (p > 0.05). The positive response and cure–improvement rates, and treatment satisfaction were significantly higher in Group 2 than in Group 1 (p < 0.05).
Conclusion
MStim added to BT is more effective than BT alone in women with idiopathic OAB.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.